IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens

Background: Recurrence of hepatitis C virus (HCV) infection following orthotopic liver transplantation (OLT) is universal. There is paucity of data on the safety and efficacy of interleukin (IL)-2 receptor antagonist (IL-2RA) when added to the standard immunosuppression regimen in OLT recipients wit...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hanouneh, I. A., Zein, N. N., Lopez, R., Yerian, L., Fung, J., Eghtesad, B.
Format: Artigo
Langue:Inglês
Publié: Avicenna Organ Transplantation Institute 2010
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4089216/
https://ncbi.nlm.nih.gov/pubmed/25013557
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires